Related Experiment Videos
[Coronary artery aneurysms]
Insights
Coronary artery aneurysms are rare but manageable. This study found that while prognosis is generally favorable, platelet aggregation inhibitors are recommended to prevent thrombosis, with surgery reserved for exceptional cases.
Area of Science:
- Cardiology
- Vascular Medicine
Background:
- Coronary artery aneurysms (CAAs) are uncommon vascular conditions.
- Diagnosis is primarily achieved through angiography.
- Etiologies include coronary artery sclerosis, congenital malformations, and inflammatory diseases.
Purpose of the Study:
- To investigate the clinical relevance, prognosis, and treatment of coronary artery aneurysms.
- To analyze findings in patients with significant coronary artery dilatations.
Main Methods:
- Retrospective analysis of 10 patients with coronary artery aneurysms over a 7-year period.
- Clinical evaluation including patient history and diagnostic findings.
- Follow-up of up to 6 years.
Main Results:
- Coronary artery sclerosis and/or congenital malformations were identified as likely causes.
- Prognosis was not unfavorable, largely influenced by coexisting stenosing coronary sclerosis.
- Thrombosis is a significant risk, necessitating preventive measures.
Conclusions:
- Coronary artery aneurysms, while rare, do not necessarily portend a poor prognosis.
- Platelet aggregation inhibitors are recommended for thrombosis prophylaxis.
- Surgical intervention for dilated vascular disorders should be exceptional.
Abstract:
Coronary artery aneurysms are rare and are diagnosed almost exclusively by angiography. Apart from a particular form of coronary artery sclerosis congenital malformations and various inflammatory diseases are to be considered aetiologically. Different opinions exist as to the clinical relevance and prognosis as well as to the necessary treatment of coronary artery aneurysms. Over the last 7 years we have observed 10 patients with in part grotesque dilatations of the coronary arteries. Based on the history and the other findings coronary sclerosis or/and congenital malformations had to be assumed. Follow-up of up to 6 years permits not an unfavourable prognosis which is more determined by the accompanying stenosing coronary sclerosis. Due to the danger of thromboses prophylaxis with platelet aggregation inhibitors is recommended. In dilated vascular disorders only surgery should be considered as the exception.